Zomedica Announces 2021 Annual Meeting Results

Zomedica Corp. (NYSE American: ZOM) held its 2021 Annual Virtual-Only Meeting on July 30, 2021, where shareholders approved key corporate governance items.

Rhea-AI Summary

Zomedica Corp. (NYSE American: ZOM) held its 2021 Annual Virtual-Only Meeting on July 30, 2021, where shareholders approved key corporate governance items. The meeting resulted in the election of new directors including Jeffrey Rowe and Robert Cohen, as well as the appointment of Grant Thornton LLP as the company's auditors. The board is authorized to determine their remuneration. The company focuses on providing innovative diagnostics and medical devices for companion animals, aiming to enhance veterinary practice efficiency.

Positive

• Election of experienced directors enhances governance.
• Appointment of Grant Thornton LLP may improve financial oversight.

Negative

• None.

Argus Session date unavailable

-0.26% session move Open Argus

Details

News Market Reaction – ZOM

The recorded move for ZOM in the trading session of this news was -0.26%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ANN ARBOR, Mich., July 30, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for companion animals, today announced the voting results of its 2021 Annual Virtual-Only Meeting of Shareholders (the “Meeting”) held on July 30, 2021.

At the Meeting, the Company’s shareholders approved the items of business as follows:

• Election of Jeffrey Rowe, Robert Cohen, Johnny D. Powers, Rodney Williams, Chris MacLeod and Christopher Wolfenberg as directors; and
• Appointment of Grant Thornton LLP as the auditors of the Company and authorization of the board of directors of the Company to fix their remuneration.

Additional information regarding the voting on these matters will be filed separately by the Company on SEDAR (www.sedar.com) and EDGAR (www.sec.gov).

About Zomedica
Based in Ann Arbor, Michigan, Zomedica (NYSE American: ZOM) is a veterinary health company creating products for dogs and cats by focusing on the unmet needs of clinical veterinarians. Zomedica’s product portfolio will include innovative diagnostics and medical devices that emphasize patient health and practice health. It is Zomedica’s mission to provide veterinarians the opportunity to increase productivity and grow revenue while better serving the animals in their care. For more information, visit www.ZOMEDICA.com.

Follow Zomedica

• Email Alerts: http://investors.zomedica.com
• LinkedIn: https://www.linkedin.com/company/zomedica

Investor Relations Contact:
PCG Advisory
Kirin Smith, President
ksmith@pcgadvisory.com
+1 646.863.6519

 

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What happened at Zomedica's 2021 Annual Meeting?

Zomedica's shareholders approved the election of new directors and the appointment of Grant Thornton LLP as auditors.

Who were the newly elected directors at Zomedica?

The new directors elected include Jeffrey Rowe, Robert Cohen, Johnny D. Powers, Rodney Williams, Chris MacLeod, and Christopher Wolfenberg.

When was Zomedica's 2021 Annual Meeting held?

Zomedica's 2021 Annual Virtual-Only Meeting was held on July 30, 2021.

What is the significance of Grant Thornton LLP being appointed as auditors for Zomedica?

The appointment of Grant Thornton LLP is expected to enhance Zomedica's financial oversight and auditing processes.